During the past decade, Kansas City Heart Rhythm Institute conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 1 clinical trials were completed, i.e. on average, 2.7% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 1 clinical trials were completed. i.e. 3.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kansas City Heart Rhythm Institute" #1 sponsor was "Kansas City Heart Rhythm Research Foundation" with 15 trials, followed by "Abbott Medical Devices" with 7 trials sponsored, "AtriCure, Inc." with 3 trials sponsored, "Acutus Medical" with 2 trials sponsored and "Boston Scientific Corporation" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kansas City Heart Rhythm Institute" #1 collaborator was "Kansas City Heart Rhythm Institute" with 3 trials as a collaborator, "Kansas City Heart Rhythm Institute, Overland Park, KS" with 2 trials as a collaborator, "Texas Cardiac Arrhythmia Research Foundation" with 2 trials as a collaborator, "CardiaBase" with 1 trials as a collaborator and "Cardiac Arrhythmia Service, Loma Linda University Health, Loma Linda, CA" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Kansas City Heart Rhythm Institute" are "Atrial Fibrillation" (16 trials), "Stroke" (5 trials), "Heart Failure" (4 trials), "Bradycardia" (3 trials) and "Cardiac Rhythm Disorder" (3 trials). Many other conditions were trialed in "Kansas City Heart Rhythm Institute" in a lesser frequency.

Most popular intervention types in "Kansas City Heart Rhythm Institute" are "Device" (21 trials), "Other" (11 trials), "Drug" (5 trials), "Procedure" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "LARIAT + PVI" (2 trials), "3D electroanatomical mapping alone guided CTI ablation" (1 trials), "AFib detection with wearable smart watch" (1 trials), "AcQMap System" (1 trials) and "Amulet Left Atrial Appendage Occluder" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kansas City Heart Rhythm Institute" are 37 trials for "All" genders.

Currently, there are 29 active trials in "Kansas City Heart Rhythm Institute". 8 are not yet recruiting, 8 are recruiting, 12 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 3 completed trials in Kansas City Heart Rhythm Institute, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Kansas City Heart Rhythm Institute, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 22 trials that are defined as “Not Applicable".